Q2 2026 revenue reached $22.8M, with net loss and adjusted EBITDA loss both significantly reduced year-over-year. Gross margin improved to 78%, and cost alignment initiatives drove a 16% decrease in operating expenses. Full-year guidance is reaffirmed, with China shipments set to resume in early 2027.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.